Literature DB >> 29359314

A utility-based design for randomized comparative trials with ordinal outcomes and prognostic subgroups.

Thomas A Murray1, Ying Yuan2, Peter F Thall2, Joan H Elizondo3, Wayne L Hofstetter4.   

Abstract

A design is proposed for randomized comparative trials with ordinal outcomes and prognostic subgroups. The design accounts for patient heterogeneity by allowing possibly different comparative conclusions within subgroups. The comparative testing criterion is based on utilities for the levels of the ordinal outcome and a Bayesian probability model. Designs based on two alternative models that include treatment-subgroup interactions are considered, the proportional odds model and a non-proportional odds model with a hierarchical prior that shrinks toward the proportional odds model. A third design that assumes homogeneity and ignores possible treatment-subgroup interactions also is considered. The three approaches are applied to construct group sequential designs for a trial of nutritional prehabilitation versus standard of care for esophageal cancer patients undergoing chemoradiation and surgery, including both untreated patients and salvage patients whose disease has recurred following previous therapy. A simulation study is presented that compares the three designs, including evaluation of within-subgroup type I and II error probabilities under a variety of scenarios including different combinations of treatment-subgroup interactions.
© 2018, The International Biometric Society.

Entities:  

Keywords:  Group sequential; Hierarchical model; Non-proportional odds; Ordinal response; Precision medicine

Mesh:

Year:  2018        PMID: 29359314      PMCID: PMC6054910          DOI: 10.1111/biom.12842

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  17 in total

1.  Design and analysis of trials with quality of life as an outcome: a practical guide.

Authors:  S J Walters; M J Campbell; R Lall
Journal:  J Biopharm Stat       Date:  2001       Impact factor: 1.051

2.  Proposed classification of complications of surgery with examples of utility in cholecystectomy.

Authors:  P A Clavien; J R Sanabria; S M Strasberg
Journal:  Surgery       Date:  1992-05       Impact factor: 3.982

Review 3.  Complications of esophageal resection and reconstruction.

Authors:  Kalpaj Parekh; Mark D Iannettoni
Journal:  Semin Thorac Cardiovasc Surg       Date:  2007

Review 4.  Ordinal logistic regression models: application in quality of life studies.

Authors:  Mery Natali Silva Abreu; Arminda Lucia Siqueira; Clareci Silva Cardoso; Waleska Teixeira Caiaffa
Journal:  Cad Saude Publica       Date:  2008       Impact factor: 1.632

5.  Using binary logistic regression models for ordinal data with non-proportional odds.

Authors:  R Bender; U Grouven
Journal:  J Clin Epidemiol       Date:  1998-10       Impact factor: 6.437

6.  Nutritional approach in malnourished surgical patients: a prospective randomized study.

Authors:  Marco Braga; Luca Gianotti; Luca Nespoli; Giovanni Radaelli; Valerio Di Carlo
Journal:  Arch Surg       Date:  2002-02

7.  Sample size calculations for ordered categorical data.

Authors:  J Whitehead
Journal:  Stat Med       Date:  1993-12-30       Impact factor: 2.373

8.  Utility-based designs for randomized comparative trials with categorical outcomes.

Authors:  Thomas A Murray; Peter F Thall; Ying Yuan
Journal:  Stat Med       Date:  2016-05-18       Impact factor: 2.373

9.  Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology.

Authors:  Werner Brannath; Emmanuel Zuber; Michael Branson; Frank Bretz; Paul Gallo; Martin Posch; Amy Racine-Poon
Journal:  Stat Med       Date:  2009-05-01       Impact factor: 2.373

10.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

View more
  5 in total

1.  BOIN12: Bayesian Optimal Interval Phase I/II Trial Design for Utility-Based Dose Finding in Immunotherapy and Targeted Therapies.

Authors:  Ruitao Lin; Yanhong Zhou; Fangrong Yan; Daniel Li; Ying Yuan
Journal:  JCO Precis Oncol       Date:  2020-11-16

2.  BAGS: A Bayesian Adaptive Group Sequential Trial Design With Subgroup-Specific Survival Comparisons.

Authors:  Ruitao Lin; Peter F Thall; Ying Yuan
Journal:  J Am Stat Assoc       Date:  2020-11-30       Impact factor: 4.369

3.  TITE-BOIN12: A Bayesian phase I/II trial design to find the optimal biological dose with late-onset toxicity and efficacy.

Authors:  Yanhong Zhou; Ruitao Lin; J Jack Lee; Daniel Li; Li Wang; Ruobing Li; Ying Yuan
Journal:  Stat Med       Date:  2022-01-31       Impact factor: 2.497

4.  Precision Bayesian phase I-II dose-finding based on utilities tailored to prognostic subgroups.

Authors:  Juhee Lee; Peter F Thall; Pavlos Msaouel
Journal:  Stat Med       Date:  2021-07-09       Impact factor: 2.497

5.  Estimating design operating characteristics in Bayesian adaptive clinical trials.

Authors:  Shirin Golchi
Journal:  Can J Stat       Date:  2022-04-15       Impact factor: 0.758

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.